Priscilla W Tang

5PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 20, 2025
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.

Amal T Elhaw, Priscilla W Tang, Ya-Yun Cheng

|Jul 09, 2025
Loss of Predicted Cell Adhesion Molecule MPZL3 Promotes EMT in Ovarian Cancer.

Ya-Yun Cheng, Beth L Worley, Zaineb Javed

|Nov 28, 2024
Loss of the predicted cell adhesion molecule MPZL3 promotes EMT and chemoresistance in ovarian cancer.

Ya-Yun Cheng, Beth L Worley, Zaineb Javed

|Aug 07, 2023
Insights into the tumor-stromal-immune cell metabolism cross talk in ovarian cancer.

Priscilla W Tang, Leonard Frisbie, Nadine Hempel

Pageof 1